中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Endostatin inhibits angiogenesis by suppressing matrix metalloproteinase-2

文献类型:期刊论文

作者Xin J(欣坚); Ma XC(马小超); Deng H(邓辉); Zhang T(张婷); Tu CH(屠曾宏)
刊名Chinese Journal of Pharmacology and Toxicology
出版日期2003
卷号17期号:5页码:389-394
关键词endostatin fibroblast growth factor, basic umbilical veins matrix metalloproteinase
ISSN号1000-3002
其他题名内皮抑制素通过抑制基质金属蛋白酶-2而抑制血管新生
文献子类Article
英文摘要AIM To study mechanisms involved in antiangiogenic effect of endostatin. METHODS Human umbilical vein endothelial cells (HUVEC) were isolated and treated with basic fibroblast growth factor (bFGF). 3D-collagen gel model was used to determine the angiogenesis of HUVEC. Activity of matrix metalloproteinase (MMP) in culture medium was analyzed by gelatin zymography and Western blot. RT-PCR was used to determine mRNA levels of MMP. RESULTS Endostatin inhibited the angiogenesis of HUVEC induced by bFGF. Endostatin inhibited the expression and the mRNA level of MMP-2 in a concentration-dependent manner. CONCLUSION MMP-2 inhibition plays an important role in antiangiogenic effect of endostatin.
WOS研究方向Pharmacology & Pharmacy (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:1494387
源URL[http://119.78.100.183/handle/2S10ELR8/268441]  
专题药物安全性评价中心
作者单位1.Shanghai Institute of Materia Medica, Chinese Academy of Sciences, State Key Laboratory of Drug Research, ShangHai 201203, China.;
2.Department of Dermatology, Huashan Hospital, Medical Department of Fudan University, ShangHai 200040, China.
推荐引用方式
GB/T 7714
Xin J,Ma XC,Deng H,et al. Endostatin inhibits angiogenesis by suppressing matrix metalloproteinase-2[J]. Chinese Journal of Pharmacology and Toxicology,2003,17(5):389-394.
APA 欣坚,马小超,邓辉,张婷,&屠曾宏.(2003).Endostatin inhibits angiogenesis by suppressing matrix metalloproteinase-2.Chinese Journal of Pharmacology and Toxicology,17(5),389-394.
MLA 欣坚,et al."Endostatin inhibits angiogenesis by suppressing matrix metalloproteinase-2".Chinese Journal of Pharmacology and Toxicology 17.5(2003):389-394.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。